You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
IPS-Integrated Project Services booth on the INTERPHEX show floor
Insights

INTERPHEX 2024

To support our corporate sustainability initiatives, we have reduced the amount of printed materials given out a tradeshows and conferences.

Please find the digital versions of our handouts below as well as links to expert insights

IPS Company Overview

IPS-Integrated Project Services, a Berkshire Hathaway company, was founded in 1989 as a unique firm focused on aligning services with our client’s business drivers and delivering projects on an integrated design-build platform. It was innovative and bold at that time. Since then, we have developed, executed, and advanced a number of strategies to reach our global status today.

Scaling your CAR-T Operation

As pioneers in the field, we also understand the deep-seated aspirations that drive you. The CAR-T revolution has set in motion a seismic shift, empowering us to combat previously incurable diseases at their very core. These therapies harness the body’s own immune system, reprogramming it to wage a precise and personalized war against cancer and other devastating conditions. Imagine the immense possibilities that unfold when we empower the cells within us to serve as warriors, battling disease with a ferocity unparalleled in medical history.

Expert Insights into the Life Sciences Community

Aseptic Technology

Designing Aseptic Facilities Amid Changing Business Driver and Technologies

Critical Elements of Implementing Advanced Aseptic Technology

ATMPs and Cell & Gene Therapy

The Challenges of Multiproduct Facility Design

Cell and Ex Vivo Gene Therapies: A Manufacturing Odyssey

Getting to Grips with mRNA

Biomanufacturing and Biotechnology

Rapid Deployment of Manufacturing Options: An Analysis of Risks and Benefits

Large-Scale Manufacturing Facility

Technology Transfer for Pharma: One Size Does Not Fit All

Pharma 4.0

IT/OT Convergence: The Path to Pharma 4.0

Pharma 4.0 Part 1: Welcome to a Smarter Way of Manufacturing

iLab - Intelligent Lab of the Future

How to Standardize and Replicate P&ID Data

Annex 1

Annex 1 - The Brave New World of Regulatory Compliance

Preparing for the Annex 1 Revision: A Holistic Approach to Contamination Control

close

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue

We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more.